$0.281
+0 (+0%)
At Close: Apr 01, 2026
Pharmaceutical, Biotech and Banking Companies Lead the Way in Social Responsibility
09:06pm, Tuesday, 13'th Oct 2020
Some surprising leaders sit atop the social-capital category in the WSJ’s top 100 sustainably managed companies
Possible Safety Issue Spurs Pause Of COVID-19 Antibody Study
08:52pm, Tuesday, 13'th Oct 2020
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly thats similar to a treatment Pr
Possible safety issue spurs pause of COVID-19 antibody study
08:38pm, Tuesday, 13'th Oct 2020
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly
Possible safety issue spurs pause of COVID-19 antibody study
08:37pm, Tuesday, 13'th Oct 2020
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly
Possible safety issue spurs pause of COVID-19 antibody study
08:36pm, Tuesday, 13'th Oct 2020
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a...
FA chairman condemns Project Big Picture as grab for power and wealth
08:30pm, Tuesday, 13'th Oct 2020
Greg Clarke said the Project Big Picture proposals amount to a move for more wealth and power by the top clubs
Johnson & Johnson stock underperforms Tuesday when compared to competitors
08:25pm, Tuesday, 13'th Oct 2020
Shares of Johnson & Johnson slid 2.29% to $148.36 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...
Boeing Deliveries Were Terrible. The Stock Reacted as Much to Vaccine News.
08:20pm, Tuesday, 13'th Oct 2020
Delivery numbers illustrate the depths of the Covid-induced commercial aerospace downturn. Virus news remains the key driver of the stock.
J&J estudia "enfermedad inexplicable" en voluntario que llevó a pausar los ensayos de su vacuna
08:12pm, Tuesday, 13'th Oct 2020
La farmacéutica Johnson & Johnson suspendió los ensayos clínicos de su potencial vacuna contra el coronavirus debido a que uno de los voluntarios del estudio presentó una enfermedad. La compañía
Stocks snap 4-day winning streak as coronavirus vaccine, treatment hit snags
08:08pm, Tuesday, 13'th Oct 2020
Stocks ended lower Tuesday, snapping a four-day winning streak for major indexes, as investors weighed separate setbacks in trials for a COVID-19 vaccine and...
Johnson & Johnson supera le stime di Wall Street nel Q3 | Invezz
07:59pm, Tuesday, 13'th Oct 2020
Johnson & Johnson supera le stime di Wall Street nel Q3 e registra £16,27 miliardi di entrate e £1,70 di EPS rettificato nel Q3.
Johnson & Johnson overtreft de schattingen van Wall Street | Invezz
07:53pm, Tuesday, 13'th Oct 2020
Johnson & Johnson overtreft de schattingen van Wall Street in Q3. J&J rapporteert £16,27 miljard aan inkomsten en £1,70 aan winst per aandeel.
Así va el desarrollo de vacunas contra el covid-19 que están en fase 3 | CNN
07:44pm, Tuesday, 13'th Oct 2020
Este es el estado de las vacunas contra el coronavirus en el mundo. Al menos seis vacunas se están probando en ensayos de fase 3. | CNN Radio Argentina, Salud | CNN
Sign In
Buy HOFV